Proteomics market is anticipated to grow at a significant CAGR of 9.7% during the forecast period. Personalized medicine has entered mainstream clinical practice and is transforming the way many diseases are detected, classified, and treated. It has become a fundamental topic of research in the healthcare business. Oncology is one area where these gains are particularly noticeable. The number of tailored medications, therapies, and diagnostic devices has expanded dramatically from 21% in 2014 to 42% in 2018, according to the Personalized Medicine Coalition report (2018), and this trend is projected to continue in the coming years. Furthermore, during the previous five years, biopharmaceutical companies have nearly doubled their R&D investments in customized medicine, and this trend is projected to continue in the next five years.
Proteomic analysis is a strong and appealing method for determining the molecular profiles of various tissues, whether healthy or sick. Personalized proteomics, also known as proteome profiling, is the next great step in personalized medicine; it clarifies illness pathomechanisms. This research identifies several indicators for a given condition and aids in the identification of protein targets for licensed medications, enabling therapeutic repositioning. This will have a direct impact on clinical practices by impacting key management and care features. These biomarkers can also be investigated for their therapeutic potential and future validation, as well as their utility as repeatable, sensitive, and specific diagnostic indicators.
The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. For instance, Perkin Elmer introduced the SARS-COV-2 Antigen Elisa Test in 2020. The IP2 software from Integrated Proteomics Applications was purchased by Bruker Corp. in 2020.
To Request a Sample of our Report on Proteomics market : https://www.omrglobal.com/request-sample/proteomics-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Product and Services
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corp., Danaher Corp., GE Healthcare, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Inc., and Waters Corp, among others.
Proteomics Market Report Segment
By Product
- Instrumentation Technology
- Spectroscopy
- Chromatography
- Electrophoresis
- Protein Microarrays
- X-Ray Crystallography
- Other Instrumentation Technologies
- Reagents
- Software and Services
By Application
- Clinical Diagnostics
- Drug Discovery
- Other Applications
A full report of Proteomics Market is available at: https://www.omrglobal.com/industry-reports/proteomics-market
Proteomics Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Activx Biosciences, Inc.
- Affymetrix, Inc.
- Agilent Technologies
- Amgen Inc
- Applied Biosystems, Inc.
- ASTERAND PLC
- BAYER AG
- Beckman Coulter, Inc.
- Becton, Dickinson, And Co.
- Biacore International Ab
Reasons to Buy From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
